Concepedia

Author

Michael Kaleko

Research Institute for Genetic and Human TherapyORCID

Also Known As

M Kaleko, M. KALEKO, M. Kaleko, Michael KALEKO, Michael Kaleko

87

Publications

4.7K

Citations

40

H-Index

92

Concepts

All Affiliations

Research Institute for Genetic and Human TherapyNovartis (United States)Fred Hutch Cancer CenterSynthetic Biologics (United States)Cosmos Corporation (United States)
MK

About

Michael Kaleko is an author at Research Institute for Genetic and Human Therapy specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

26

2.3K

2

Health Sciences

8

8

382

3

Engineering

3

3

191

4

Natural Sciences

1

1

18

5

Biochemistry

1

1

73

Michael Kaleko

×

61

Publications

4.6K

Citations

40

H-Index

YearCitations

Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

Michael Kaleko, William J. Rutter, A. Dusty Miller

Molecular and Cellular Biology

1990

399

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

Theodore A Smith, Michele G. Mehaffey, Dawn B. Kayda,

Nature Genetics

1993

342

Adenovirus Serotype 5 Fiber Shaft Influences <i>In Vivo</i> Gene Transfer in Mice

Theodore A Smith, Neeraja Idamakanti, Michele L. Rollence,

Human Gene Therapy

2003

214

Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor.

V R Chazin, Michael Kaleko, A. Dusty Miller,

PubMed

1992

172

Receptor Interactions Involved in Adenoviral-Mediated Gene Delivery After Systemic Administration in Non-Human Primates

Theodore A Smith, Neeraja Idamakanti, Jennifer Marshall-Neff,

Human Gene Therapy

2003

136

In Vivo Hepatic Adenoviral Gene Delivery Occurs Independently of the Coxsackievirus–Adenovirus Receptor

Theodore A Smith, Neeraja Idamakanti, Helen Kylefjord,

Molecular Therapy

2002

136

Intraocular expression of endostatin reduces VEGF‐induced retinal vascular permeability, neovascularization, and retinal detachment

Kyoichi Takahashi, Yoshitsugu Saishin, Yumiko Saishin,

The FASEB Journal

2003

130

Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector.

Theodore A Smith, Brian D. White, Joann M. Gardner,

PubMed

1996

128

Development of adenovirus serotype 35 as a gene transfer vector

P. Seshidhar Reddy, Shanthi Ganesh, M.Paullin Limbach,

Virology

2003

127

Sustained Human Factor VIII Expression in Hemophilia A Mice Following Systemic Delivery of a Gutless Adenoviral Vector

P. Seshidhar Reddy, Kiran Sakhuja, Shanthi Ganesh,

Molecular Therapy

2002

117

Page 1